🔎 Trials Near Me

Beranda › Kanker (semua jenis) › Pennsylvania › Philadelphia

Uji klinis Kanker (semua jenis) di Philadelphia, PA

59 studi untuk Kanker (semua jenis) mencari peserta di lokasi sekitar Philadelphia (dalam radius sekitar 30 mil). Buka studi untuk melihat kriteria peserta dan cara menghubungi tim studi.

Teks studi resmi (Bahasa Inggris)

Merekrut peserta untuk studi di sini? Tampilkan di bagian atas halaman ini — $99 selama 30 hari →

Autoimmunity After Checkpoint Blockade

Menerima pesertaStudi observasional
  • University of Pennsylvania - Abramson Cancer Center, Philadelphia
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 5 Okt 2026 · NCT04119713

A First-in-Human Study of KK2223 in Participants With Relapsed or Refractory T Cell Non-Hodgkin Lymphoma

Menerima pesertaFase 1
  • University of Pennsylvania - Abramson Cancer Center, Philadelphia
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 30 Sep 2026 · NCT07192471

A Study of GSK5764227 in Combination With Standard of Care (SoC) or Other Agents in Participants With Advanced Solid Tumors

Menerima pesertaFase 1
  • GSK Investigational Site, Philadelphia
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 25 Sep 2026 · NCT07277270

A Study of Ifinatamab Deruxtecan in Pediatric Participants With Relapsed or Refractory Solid Tumors (MK-9999-01D/LIGHTBEAM-U01)

Menerima pesertaFase 1/2
  • Children's Hospital of Philadelphia (CHOP) ( Site 4021), Philadelphia
1 Month – 17 Years · Semua jenis kelamin · Diperbarui 25 Sep 2026 · NCT07630974

A Study of JNJ-88549968 for the Treatment of Calreticulin (CALR)-Mutated Myeloproliferative Neoplasms

Menerima pesertaFase 1
  • University of Pennsylvania, Philadelphia
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 25 Sep 2026 · NCT06150157

A Study Evaluating Sotorasib Platinum Doublet Combination Versus Pembrolizumab Platinum Doublet Combination as a Front-Line Therapy in Participants With Stage IV or Advanced Stage IIIB/C Nonsquamous Non-Small Cell Lung Cancers (CodeBreaK 202)

Menerima pesertaFase 3
  • Alliance Cancer Specialists - Media, Media · 12 mi jauhnya
Usia 18 hingga 100 · Semua jenis kelamin · Diperbarui 25 Sep 2026 · NCT05920356

First Time in Human (FTIH) Study to Investigate the Safety and Preliminary Activity of GSK5533524 Alone or in Combination in Adult Participants With Advanced Solid Tumors

Menerima pesertaFase 1
  • GSK Investigational Site, Philadelphia
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 25 Sep 2026 · NCT07438782

Extension Study for Participants in Studies That Include Belzutifan (MK-6482-043/LITESPARK-043)

Menerima pesertaFase 3
  • Hospital of the University of Pennsylvania Perelman Center for Advanced Medicine ( Site 0100), Philadelphia
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 23 Sep 2026 · NCT07405164

TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer

Menerima pesertaFase 2
  • Fox Chase Cancer Center, Philadelphia
Usia 12 ke atas · Semua jenis kelamin · Diperbarui 22 Sep 2026 · NCT02693535

Long-Term Follow-up Protocol for Participants Treated With Gene-Modified T Cells

Menerima pesertaFase 2/3
  • University of Pennsylvania Perelman Center for Advanced Medicine, Philadelphia
  • Thomas Jefferson University - Clinical Research Institute, Philadelphia
  • Fox Chase Cancer Center, Philadelphia
Semua usia · Semua jenis kelamin · Diperbarui 18 Sep 2026 · NCT03435796

A Study of Patritumab Deruxtecan in Pediatric Participants With Relapsed or Refractory Solid Tumors (MK-9999-01C/LIGHTBEAM-U01)

Menerima pesertaFase 1/2
  • Children's Hospital of Philadelphia (CHOP) ( Site 3021), Philadelphia
1 Month – 17 Years · Semua jenis kelamin · Diperbarui 17 Sep 2026 · NCT06941272

RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses

Menerima pesertaFase 2
  • University of Pennsylvania, Philadelphia
Usia 18 hingga 80 · Semua jenis kelamin · Diperbarui 15 Sep 2026 · NCT07002034

A Study to Investigate Safety and Effectiveness of Tacabrutideg (BGB-16673) in Combination With Other Agents in Participants With Relapsed or Refractory B-Cell Malignancies

Menerima pesertaFase 1/2
  • Fox Chase Cancer Center, Philadelphia
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 11 Sep 2026 · NCT06634589

A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer

Menerima pesertaFase 3
  • Thomas Jefferson University, Sidney Kimmel Cancer Center - Clinical Trials Office, Philadelphia
  • USO - Alliance Cancer Specialists, PC, Horsham · 16 mi jauhnya
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 8 Sep 2026 · NCT06119581

A Longitudinal Multi-Omic Biomarker Profiling Study of Patients With Head & Neck Squamous Cell Carcinoma (HNSCC)

Menerima pesertaStudi observasional
  • University of Pennsylvania, Philadelphia
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 3 Sep 2026 · NCT06163534

Lurbinectedin in FET-Fused Tumors

Menerima pesertaFase 1/2
  • Children's Hospital of Philadelphia, Philadelphia
Usia 10 ke atas · Semua jenis kelamin · Diperbarui 2 Sep 2026 · NCT05918640

IMmunotherapy: Prospective Assessment of Cannabis Treatment in Cancer

Menerima pesertaStudi observasional
  • Thomas Jefferson University, Philadelphia
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 26 Agu 2026 · NCT06206941

Project: Every Child for Younger Patients With Cancer

Menerima pesertaStudi observasional
  • Drexel University School of Medicine, Philadelphia
  • Children's Hospital of Philadelphia, Philadelphia
  • Saint Christopher's Hospital for Children, Philadelphia
  • dan 1 lainnya
Hingga usia 25 · Semua jenis kelamin · Diperbarui 25 Agu 2026 · NCT02402244

Abatacept in Immune Checkpoint Inhibitor Myocarditis

Menerima pesertaFase 3
  • University of Pennsylvania, Philadelphia
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 20 Agu 2026 · NCT05335928

Indirect Calorimetry-Guided Parenteral Nutrition Prescribing in Oncology Patients

Menerima peserta
  • Fox Chase Cancer Center, Philadelphia
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 20 Agu 2026 · NCT07776704

A Study of Tulmimetostat DZR123 (CPI-0209) in Patients With Advanced Solid Tumors and Lymphomas

Menerima pesertaFase 1/2
  • Abramson Cancer Center of the University of Pennsylvania, Philadelphia
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 19 Agu 2026 · NCT04104776

FOG-001 in Locally Advanced or Metastatic Solid Tumors

Menerima pesertaFase 1/2
  • University of Pennsylvania, Perelman School of Medicine, Philadelphia
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 17 Agu 2026 · NCT05919264

Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer

Menerima pesertaFase 3
  • University of Pennsylvania/Abramson Cancer Center, Philadelphia
  • Pennsylvania Hospital, Philadelphia
  • Thomas Jefferson University Hospital, Philadelphia
  • dan 5 lainnya
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 7 Agu 2026 · NCT06580314

Illuminate: A Clinical Study Evaluating CAR T Immune Cell Therapy (BCB-276) for Patients With Diffuse Intrinsic Pontine Glioma (DIPG).

Menerima pesertaFase 2
  • Children's Hospital of Philadelphia, Philadelphia
Usia 1 hingga 26 · Semua jenis kelamin · Diperbarui 4 Agu 2026 · NCT07680439

Selpercatinib Pre-RAI in Patients With RET Fusion Thyroid Cancer (RAISE)

Menerima pesertaFase 2
  • Children's Hospital of Philadelphia, Philadelphia
Usia 2 hingga 25 · Semua jenis kelamin · Diperbarui 24 Jul 2026 · NCT06458036

Testing eSCCIP: An eHealth Psychosocial Intervention for English and Spanish Speaking Parents of Children With Cancer

Menerima pesertaSukarelawan sehat diterima
  • Nemours Children's Health, Delaware, Wilmington · 25 mi jauhnya
Semua usia · Semua jenis kelamin · Diperbarui 17 Jul 2026 · NCT05294302

Evaluation of Grief Therapy Approaches for Bereaved Parents

Menerima peserta
  • Children's Hospital of Philadelphia (Data Collection Only), Philadelphia
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 1 Jul 2026 · NCT05142605

Molecular Genetics Studies of Cancer Patients and Their Relatives

Menerima pesertaStudi observasionalSukarelawan sehat diterima
  • Paoli Memorial Hospital, Paoli · 18 mi jauhnya
Semua usia · Semua jenis kelamin · Diperbarui 29 Jun 2026 · NCT04185935

Childhood Cancer Survivor Study

Menerima pesertaStudi observasionalSukarelawan sehat diterima
  • Children's Hospital of Philadelphia, Philadelphia
Semua usia · Semua jenis kelamin · Diperbarui 17 Jun 2026 · NCT01120353

Preventing Liver Cancer Mortality Through Imaging With Ultrasound vs. MRI

Menerima peserta
  • Corporal Michael J. Crescenz VA Medical Center, Philadelphia, PA, Philadelphia
Usia 18 hingga 75 · Semua jenis kelamin · Diperbarui 17 Jun 2026 · NCT05486572

Engaging M-health for Symptom Monitoring and Health Promotion for Women on Endocrine Therapy for Breast Cancer (EmSHAPE)

Menerima peserta
  • Abramson Cancer Center at the University of Pennsylvania, Philadelphia
Usia 18 ke atas · Wanita · Diperbarui 12 Jun 2026 · NCT07454499

CT-95 in Advanced Cancers Associated With Mesothelin Expression

Menerima pesertaFase 1
  • University of Pennsylvania, Philadelphia
  • Context Investigational Site, Philadelphia
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 12 Jun 2026 · NCT06756035

Synovial Sarcoma Registry / Biospecimen Repository

Menerima pesertaStudi observasional
  • Children's Hospital of Philadelphia, Philadelphia
Semua usia · Semua jenis kelamin · Diperbarui 9 Jun 2026 · NCT05910307

Study With ABBV-CLS-484 in Participants With Locally Advanced or Metastatic Tumors

Menerima pesertaFase 1
  • Perelman Center for Advanced Medicine /ID# 250188, Philadelphia
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 4 Jun 2026 · NCT04777994

Assessment of Multi-Level Interventions to Improve Adherence to Oral Medications in Cancer Patients

Menerima peserta
  • Albert Einstein Healthcare Network, Philadelphia
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 29 Mei 2026 · NCT03245411

ACTengine® IMA203/IMA203CD8 as Monotherapy or in Combination With Nivolumab in Recurrent and/or Refractory Solid Tumors

Menerima pesertaFase 1/2
  • University of Pennsylvania, Perelamn Center for Advanced Medicine, Philadelphia
  • Thomas Jefferson University, Honickman Center, Philadelphia
  • Fox Chase Cancer Center, Philadelphia
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 13 Mei 2026 · NCT03686124

I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer

Menerima pesertaFase 2
  • University of Pennsylvania (U Penn), Philadelphia
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 6 Mei 2026 · NCT01042379

Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of TGW101 in Participants With Advanced Solid Tumors

Menerima pesertaFase 1
  • Fox Chase Cancer Center, Philadelphia
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 16 Apr 2026 · NCT06959706

Massage Impact on Sleep in Pediatric Oncology

Menerima peserta
  • Children's Hospital of Philadelphia, Philadelphia
Usia 12 hingga 21 · Semua jenis kelamin · Diperbarui 15 Apr 2026 · NCT06892158

A Phase 1 Study of CPO301 in Adult Patients With Advanced or Metastatic Solid Tumors

Menerima pesertaFase 1
  • Fox Chase Cancer Center, Philadelphia
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 20 Mar 2026 · NCT05948865

Suprachoroidal Administration in Subjects With Metastases to the Choroid

Menerima pesertaFase 2
  • Shields and Shields, PC, Philadelphia
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 13 Mar 2026 · NCT06643884

Implementation of eHealth Delivery Alternatives for Cancer Genetic Testing for Hereditary Cancer (eREACH3)

Menerima pesertaStudi observasionalSukarelawan sehat diterima
  • Abramson Cancer Center at the University of Pennsylvania, Philadelphia
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 13 Mar 2026 · NCT07471958

TumorGlow Intraoperative Molecular Imaging (IMI)

Menerima pesertaFase 1/2
  • University of Pennsylvania, Philadelphia
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 9 Mar 2026 · NCT04723810

The Radiation Oncology Registry and Biosample Repository

Menerima pesertaStudi observasional
  • University of Pennsylvania, Philadelphia
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 4 Mar 2026 · NCT01577251

Safety, PK, and Preliminary Efficacy of MBRC-101 in Advanced Refractory Solid Tumors

Menerima pesertaFase 1/2
  • University of Pennsylvania, Abramson Cancer Center, Philadelphia
  • Fox Chase Cancer Center, Philadelphia
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 2 Mar 2026 · NCT06014658

Re-Engaging AYA Survivors in Cancer-Related Healthcare

Menerima peserta
  • Children's Hospital of Philadelphia, Philadelphia
  • Penn Medicine, Philadelphia
Usia 15 hingga 29 · Semua jenis kelamin · Diperbarui 18 Feb 2026 · NCT07138040

From Screening to Support: A Multi-Method Analysis of HRSN Integration in Cancer Care

Menerima pesertaStudi observasional
  • Sidney Kimmel Cancer Center at Thomas Jefferson University, Philadelphia
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 12 Feb 2026 · NCT07352579

Study to Assess Change in Disease Activity and Adverse Events of Oral Venetoclax With Intravenous (IV) Obinutuzumab in Adult Participants With Recurring Chronic Lymphocytic Leukemia (CLL)

Menerima pesertaFase 2
  • Pennsylvania Oncology Hematolo /ID# 249637, Philadelphia
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 9 Feb 2026 · NCT04895436

eHealth Delivery Alternative for Cancer Genetic Testing for Hereditary Cancer

Menerima pesertaSukarelawan sehat diterima
  • Abramson Cancer Center at the University of Pennsylvania, Philadelphia
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 16 Jan 2026 · NCT05427240

CARE Study: Cancer, Asian Americans, and Relationship Enrichment

Menerima pesertaSukarelawan sehat diterima
  • Fox Chase Cancer Center - Philadelphia, Philadelphia
Usia 21 hingga 80 · Semua jenis kelamin · Diperbarui 31 Des 2025 · NCT06782581

Targeted Therapy to Increase RAI Uptake in Metastatic DTC

Menerima pesertaStudi observasional
  • Children's Hospital of Philadelphia, Philadelphia
Usia 0 ke atas · Semua jenis kelamin · Diperbarui 14 Nov 2025 · NCT05024929

Larotrectinib to Enhance RAI Avidity in Differentiated Thyroid Cancer

Menerima pesertaFase 2
  • Children's Hospital of Philadelphia, Philadelphia
Usia 2 hingga 99 · Semua jenis kelamin · Diperbarui 14 Nov 2025 · NCT05783323

Cannabis Use and Outcomes in Black and White Patients With Cancer

Menerima pesertaStudi observasional
  • Thomas Jefferson University, Philadelphia
  • University of Pennsylvania, Philadelphia
Usia 21 hingga 99 · Semua jenis kelamin · Diperbarui 30 Okt 2025 · NCT06037681

Childhood Cancer Predisposition Study (CCPS)

Menerima pesertaStudi observasional
  • Children's Hospital of Philadelphia, Philadelphia
Semua usia · Semua jenis kelamin · Diperbarui 29 Okt 2025 · NCT04511806

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

Menerima pesertaStudi observasional
  • Massive Bio SYNERGY-AI site, Philadelphia
Semua usia · Semua jenis kelamin · Diperbarui 28 Okt 2025 · NCT03452774

A Prospective Registry to Enable Collection of Standardized Routine Care Oncology Patient Data

Menerima pesertaStudi observasionalSukarelawan sehat diterima
  • Lankenau Medical Center, Paoli · 18 mi jauhnya
Usia 18 hingga 120 · Semua jenis kelamin · Diperbarui 20 Okt 2025 · NCT06877884

Melanoma Margins Trial-II: 1cm v 2cm Wide Surgical Excision Margins for AJCC Stage II Primary Cutaneous Melanoma

Menerima peserta
  • Fox Chase Cancer Center, Philadelphia
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 27 Nov 2024 · NCT03860883

Performance of SGM-101 for the Delineation of Primary and Recurrent Tumor and Metastases in Patients Undergoing Surgery for Colorectal Cancer

Menerima pesertaFase 3
  • Perelman Center for Advanced Medicine, Philadelphia
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 24 Apr 2024 · NCT03659448

Uji klinis Kanker (semua jenis) di kota lain

Studi lain di Philadelphia

Dari ClinicalTrials.gov, data diambil 6 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.